Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.
Press releases published on September 2, 2025
INNOVATION MEETS CULTURE AT BOSTON’S FIRST CARIBBEAN TECH SHOWCASE ON SEPTEMBER 11
EIN Presswire
·
September 2, 2025
The Innovation Night Will Elevate Caribbean-Led Startups and Foster Global Collaboration in Fintech, Healthtech, and More. CAMBRIDGE, MA, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- On Thursday, September 11, 2025, the inaugural Caribbean …
North Shore Entrepreneur Helps Massachusetts Firms Modernize Technology and Cut Costs
EIN Presswire
·
September 2, 2025
The Deady Group launches clarity-first advisory model, helping Massachusetts firms cut costs and modernize. BOSTON, MA, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- North Shore entrepreneur William Deady, founder of The Deady Group, is …
NurseHack4Health™ Pitch-A-Thon to provide $385k grant funding for innovative healthcare solutions
EIN Presswire
·
September 2, 2025
The total grant funding available is $385,000 across three tracks and is free and open globally. BOSTON, MA, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- The Society of Nurse Scientists Innovators Entrepreneurs …
Exergen Appoints Paula McGrane as New European Commercial Director to Support Growth and Adoption
EIN Presswire
·
September 2, 2025
Paula McGrane joins Exergen as Commercial Director for Europe with extensive medical sales and strategic business planning and experience. WATERTOWN, MA, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- Exergen Corporation, a leading U.S.-based …
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status
GlobeNewswire
·
September 2, 2025
TOKYO and CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) …
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 2, 2025
SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
LEXINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and …
Flex Raises $15M to Unlock $150B in Untapped Pre-Tax Spending for Leading Health & Wellness Retailers
GlobeNewswire
·
September 2, 2025
SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Flex, the leading platform that enables health and wellness brands to accept Health Savings Account (HSA) and Flexible Spending Account (FSA) payments, has raised $15 million in Series A funding, bringing …
Vaxart Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, …
Korro to Participate in Upcoming Investor and Scientific Conferences
GlobeNewswire
·
September 2, 2025
CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences for the month of September: Citi's 2025 …
Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September
GlobeNewswire
·
September 2, 2025
TEL AVIV, Israel, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in September as follows: Morgan …
Nyxoah Announces Upcoming Investor Events
GlobeNewswire
·
September 2, 2025
Nyxoah Announces Upcoming Investor Events Mont-Saint-Guibert, Belgium – September 2, 2025, 10:30pm CET / 4:30PM ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment …
Nyxoah Annonce ses Prochains Événements Destinés aux Investisseurs
GlobeNewswire
·
September 2, 2025
Nyxoah Annonce ses Prochains Événements Destinés aux Investisseurs Mont-Saint-Guibert, Belgique – 2 septembre 2025, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de technologie médicale …
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 2, 2025
BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 54,360 restricted stock units (“RSUs”) and options to purchase 38,850 shares of the Company’s common stock to …
Sanara MedTech Inc. Announces Chief Executive Officer Transition
GlobeNewswire
·
September 2, 2025
Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical …
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
ROCKVILLE, MD, Sept. 02, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that MacroGenics’ President …
Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
HOUSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) …
Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
PARIS and CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for …
Nanobiotix participera à la conférence investisseurs annuelle H.C. Wainwright global investment
GlobeNewswire
·
September 2, 2025
PARIS et CAMBRIDGE, Mass., 02 sept. 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des approches fondées sur les …
Certara to Participate in Upcoming Investor Conferences
GlobeNewswire
·
September 2, 2025
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences: Baird Global Healthcare …